Kos Olinger咨询公司购买了132万美元的安根股票,该公司增长强劲,分析师乐观。 Koss Olinger Consulting LLC purchased $1.32 million in Amgen stock, a company seeing strong growth and analyst optimism.

Kos Olinger咨询有限公司购买了价值132万美元的Amgen公司股票,并收购了4 229股股票。 Koss Olinger Consulting LLC bought $1.32 million worth of Amgen Inc. stock, acquiring 4,229 shares. 安进股价本季度上涨24.8%，收于288.23美元，盈利超出分析师预期。 Amgen's stock has risen 24.8% this quarter, closing at $288.23, with earnings beating analysts' expectations. 该公司的产品包括自发免疫疾病、癌症和骨质疏松症的治疗。 The company's products include treatments for autoimmune diseases, cancer, and osteoporosis. Morgan Stanley将Amgen的价格目标提高到333美元,比上一个目标增长了15.7%。 Morgan Stanley raised Amgen's price target to $333, a 15.7% increase from the previous target.